Article
Author(s):
Memantine HCl (Namenda) is indicated for the treatment of moderate to severe dementia of the Alzheimer’s type.
Medication Pearl of the Day: Memantine HCl (Namenda)
Indication: Memantine HCl(Namenda) is an N-methyl-D-aspartate (NMDA) receptor antagonist indicated for the treatment of moderate to severe dementia of the Alzheimer’s type.
Insight:
Source: label (fda.gov)
Measles Cases Climb to 800 in United States as Outbreak Spreads Across Borders
FDA Approves Dupilumab, Marking First Targeted Therapy in a Decade for Chronic Spontaneous Urticaria